Dioscorea nipponica Makino: A comprehensive review of its chemical composition and pharmacology on chronic kidney disease

被引：2

作者：

Wu, Chenguang ^{[1
]}

Zhang, Rui ^{[1
]}

Wang, Jingjing ^{[1
]}

Chen, Yao ^{[1
]}

Zhu, Wenhui ^{[1
]}

Yi, Xiang ^{[1
]}

Wang, Yan ^{[2
]}

Wang, Lifan ^{[1
,5
]}

Liu, Peng ^{[3
,6
]}

Li, Ping ^{[4
,7
]}

机构：

[1] Heilongjiang Acad Chinese Med Sci, Dept Med, Renal Div, Harbin, Peoples R China

[2] Peking Univ Peoples Hosp, Dept Nephrol, Beijing, Peoples R China

[3] Shunyi Hosp, Beijing Hosp Tradit Chinese Med, Beijing, Peoples R China

[4] China Japan Friendship Hosp, Beijing Key Lab Immune Mediated Inflammatory Dis, Beijing, Peoples R China

[5] 142 Sanfu St, Harbin 150036, Peoples R China

[6] 1 Courtyard Jiansheng St, Beijing, Peoples R China

[7] 2 Yinghua Dongjie, Beijing 100029, Peoples R China

来源：

BIOMEDICINE & PHARMACOTHERAPY | 2023年 / 167卷

基金：

中国国家自然科学基金;

关键词：

Dioscorea nipponica Makino (DNM); Chronic kidney disease (CKD); Oxidative stress; Renal fibrosis; Inflammatory response; CHINESE HERBAL MEDICINE; CORONARY-HEART-DISEASE; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; DOWN-REGULATION; URIC-ACID; RAT MODEL; MITOCHONDRIAL DYSFUNCTION; MOLECULAR-MECHANISMS; RENAL-DISEASE;

D O I：

10.1016/j.biopha.2023.115508

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Chronic kidney disease (CKD) is a widespread ailment that significantly impacts global health. It is characterized by high prevalence, poor prognosis, and substantial healthcare costs, making it a major public health concern. The current clinical treatments for CKD are not entirely satisfactory, leading to a high demand for alternative therapeutic options. Chinese herbal medicine, with its long history, diverse varieties, and proven efficacy, offers a promising avenue for exploration. One such Chinese herbal medicine, Dioscorea nipponica Makino (DNM), is frequently used to treat kidney diseases. In this review, we have compiled studies examining the mechanisms of action of DNM in the context of CKD, focusing on five primary areas: improvement of oxidative stress, inhibition of renal fibrosis, regulation of metabolism, reduction of inflammatory response, and regulation of autophagy.

引用

页数：11

共 213 条

[1] Is coronary heart disease rising in India? A systematic review based on ECG defined coronary heart disease
Ahmad, N
Bhopal, R
[J]. HEART, 2005, 91 (06) : 719 - 725
[2] Update on Inflammation in Chronic Kidney Disease
Akchurin, Oleh M.
Kaskel, Frederick
[J]. BLOOD PURIFICATION, 2015, 39 (1-3) : 84 - 92
[3] Ammirati AL, 2020, REV ASSOC MED BRAS, V66, pS3, DOI [10.1590/1806-9282.66.S1.3, 10.1590/1806-9282.66.s1.3]
[4] [Anonymous], 2011, Evid. Based Complement Altern. Med
[5] Diosgenin-induced protection against myocardial ischaemia-reperfusion injury is mediated by mitochondrial KATP channels in a rat model
Badalzadeh, R.
Yousefi, B.
Tajaddini, A.
Ahmadian, N.
[J]. PERFUSION-UK, 2015, 30 (07): : 565 - 571
[6] Anti-arrhythmic effect of diosgenin in reperfusion-induced myocardial injury in a rat model: activation of nitric oxide system and mitochondrial KATP channel
Badalzadeh, Reza
Yousefi, Bahman
Majidinia, Maryam
Ebrahimi, Hadi
[J]. JOURNAL OF PHYSIOLOGICAL SCIENCES, 2014, 64 (06) : 393 - 400
[7] MicroRNA-214 promotes chronic kidney disease by disrupting mitochondrial oxidative phosphorylation
Bai, Mi
Chen, Huimei
Ding, Dan
Song, Ruihua
Lin, Jiajuan
Zhang, Yuanyuan
Guo, Yan
Chen, Shuang
Ding, Guixia
Zhang, Yue
Jia, Zhanjun
Huang, Songming
He, John Cijiang
Yang, Li
Zhang, Aihua
[J]. KIDNEY INTERNATIONAL, 2019, 95 (06) : 1389 - 1404
[8] Inhaled Corticosteroids
Barnes, Peter J.
[J]. PHARMACEUTICALS, 2010, 3 (03): : 514 - 540
[9] Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI [10.1161/CIR.0000000000000558, 10.1161/CIR.0000000000000485, 10.1161/CIR.0000000000000530]
[10] The next generation of therapeutics for chronic kidney disease
Breyer, Matthew D.
Susztak, Katalin
[J]. NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (08) : 568 - 588

← 1 2 3 4 5 6 7 8 9 10 →